Abstract: Enantiomer derivatives of 8-hydroxyquinoline derivatives with general formula (I) and (II) and the synthesis thereof and pharmaceutically acceptable salts and metal complexes thereof, and the medicinal and/or pharmaceutical compositions comprise these compounds: The compounds according to the invention can be used preferably as cytoprotective, neuroprotective, cardioprotective, anxiolytic and antidepressant agent for treatment of neuropsychiatric and neurologic diseases and diseases in connections with transplantations and with ischemia and reperfusion injuries thereof, and inhibition of organ, advantageously skin graft rejection.

Abstract: Our invention relates to novel enantiomer derivatives of 8-hydroxyquinoline derivatives with general formula (I) and (II) and the synthesis thereof and pharmaceutically acceptable salts and metal complexes thereof, and the medicinal and/or pharmaceutical compositions comprising these compounds. The essence of the subject matter of the invention relates to the fact that prior art discloses the biological effect and characteristics only of the racemic products, the novel enantiomer derivatives according to the invention appear in our application for the first. The subject matter of the invention furthermore relates to a novel, stereoselective synthesis for the preparation of the novel enantiomer derivatives according to the invention. The novel medicinal and/or pharmaceutical compositions comprising these enantiomers are suitable for the treatment of the named diseases, and the enanatiomers are used for manufacture of these compositions.

Abstract: Our invention relates to novel enantiomer derivatives of 8-hydroxyquinoline derivatives with general formula (I) and (II) and the synthesis thereof and pharmaceutically acceptable salts and metal complexes thereof, and the medicinal and/or pharmaceutical compositions comprising these compounds. The essence of the subject matter of the invention relates to the fact that prior art discloses the biological effect and characteristics only of the racemic products, the novel enantiomer derivatives according to the invention appear in our application for the first. The subject matter of the invention furthermore relates to a novel, stereoselective synthesis for the preparation of the novel enantiomer derivatives according to the invention. The novel medicinal and/or pharmaceutical compositions comprising these enantiomers are suitable for the treatment of the named diseases, and the enanatiomers are used for manufacture of these compositions.

Abstract: A method and system for generating a document for use with personal data and an image, including: inputting the personal text data into the processor; inputting the image into the processor; generating, by the processor, a personal identifier based on the personal text data, a first Message Authentication Code (MAC) based on the personal identifier; generating, by the processor, a first wave structure based on the MAC; generating, by the processor, waved microtext based on the wave structure and the personal text data; generating, by the processor, a letter screen image from the input image with the waved microtext; and outputting the letter screen image. A method and system for verification of the generated document is also disclosed.

Abstract: A method and system for generating a document for use with personal data and an image, including: inputting the personal text data into the processor; inputting the image into the processor; generating, by the processor, a personal identifier based on the personal text data, a first Message Authentication Code (MAC) based on the personal identifier; generating, by the processor, a first wave structure based on the MAC; generating, by the processor, waved microtext based on the wave structure and the personal text data; generating, by the processor, a letter screen image from the input image with the waved microtext; and outputting the letter screen image. A method and system for verification of the generated document is also disclosed.

Abstract: An apparatus and process for hiding the secondary image within the primary image and generating a high quality hard copy of the unified elemental image of a variety of media. The process comprises the steps of rasterizing the first image into an first elemental image and rasterizing the second image, compensated with its own inverse, into an second elemental image. The first elemental image and the second elemental image are merged into a unified elemental image based on a predetermined decoding and compensating principle, resulting in the second elemental image being hidden within the first elemental image. An output image is created based on the unified elemental image where the primary image is visible to an un-aided eye while the secondary image is hidden from the un-aided eye.

Abstract: The present invention relates to electro-analytical measuring equipment for the determination--by means of one or more measuring cells comprising sensing elements of chemical similar composition, being in constant galvanic contact with each other--of the concentration and ion-activity of solutions or of the partial pressure of gases. The sensing elements are in contact with sample or with one or more standardizing media separated in time or space. At least two reference electrodes are in direct or in indirect contact--through electrolite--with sample and standardizing medium. The reference electrodes join, in a given case, to electronic signal processor comprising arithmetic unit calculating, by fault compensation, value of one or more parameters to be measured.